000			nab a22 7a 4500
999			_c16718 _d16718
003			PC16718
005			20220211122640.0
008			220210b xxu||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_92984 _aSánchez Fuentes, Diana _eMedicina Nuclear
100			_92985 _aPedraza Fernández, Sara _eOncologia Radioterápica
100			_92137 _aRuiz Solís, Sebastián _eMedicina Nuclear
100			_92986 _aHernández Martínez, Ana Cristina _eMedicina Nuclear
100			_92987 _aSarandeses Fernández, Pilar _eMedicina Nuclear
100			_92988 _aGómez Grande, Adolfo _eMedicina Nuclear
100			_9436 _aPérez Escutia, Mª Ángeles _eOncología Radioterápica
100			_91645 _aEstenoz Alfaro, Juana María _eMedicina Nuclear
245	0	0	_a18F-FDG PET-CT Predicting Pathological Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer. _h[comunicación]
260			_bEuropean journal of nuclear medicine and molecular imaging, _c2015
300			_a42 Suppl 1:666.
500			_aFormato Vancouver: Sánchez Fuentes D, Pedraza Fernández S, Ruiz Solis S, Hernández Martínez A, Sarandeses Fernández P, Gómez Grande A et al. 18F-FDG PET-CT Predicting Pathological Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer. En: EANM'15, 28th Annual EANM Congress of the European Association of Nuclear Medicine 2015. Hamburg, Germany. Eur J Nucl Med Mol Imaging. 2015 Oct;42 Suppl 1:666.
501			_aPMID: 26450692 (Congreso)
504			_a
520			_aNo abstract available
710			_9414 _aServicio de Medicina Nuclear
710			_9302 _aServicio de Oncología Radioterápica
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/1/pc16718.pdf _ySolicitar documento
942			_2ddc _cCOM _n0